2.94
BATS BZX Real-Time Price
As of 2:08pm ET
 -0.16 / -5.16%
Today’s Change
1.09
Today|||52-Week Range
3.50
+96.00%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$397.9M

Company Description

Curis, Inc. is a biotechnology company, which is to develop and commercialize innovative drug candidates for the treatment of human cancers. Its pipeline includes two clinical stage drug candidates: CUDC-907, a dual HDAC and PI3K inhibitor, and CUDC-427, a small molecule IAP antagonist. The company conducts research programs both internally and through strategic collaborations. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.

Contact Information

Curis, Inc.
4 Maguire Road
Lexington Massachusetts 02421
P:(617) 503-6500
Investor Relations:
(617) 503-6605

Employees

Shareholders

Other institutional35.86%
Individual stakeholders19.96%
Mutual fund holders14.81%

Top Executives

Ali FattaeyPresident, Chief Executive Officer & Director
Michael P. GraySecretary, Chief Financial & Business Officer
Jaye VinerChief Medical Officer & Executive Vice President
Tania ChanderVice President-Product Development
Mani MohindruVP-Corporate Strategy & Investor Relations

To view my watchlist

Not a member yet?

Sign up now for a free account